GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
- Seppo Vainio
From the University of Oulu, our investigators are professors Seppo Vainio, Peppi Karppinen, and Lauri Eklund.
Please visit the GeneCellNano website at www.genecellnano.fi.